vortisi.blogg.se

Claudia mori alzheimer
Claudia mori alzheimer













ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority claimed from US45868710P external-priority Application filed by Research Foundation for Mental Hygiene Inc, New York University NYU filed Critical Research Foundation for Mental Hygiene Inc Priority to US13/307,485 priority Critical patent/US9265735B2/en Publication of US20120136064A1 publication Critical patent/US20120136064A1/en Assigned to THE RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC., NEW YORK UNIVERSITY reassignment THE RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC. Original Assignee Research Foundation for Mental Hygiene Inc New York University NYU Priority date (The priority date is an assumption and is not a legal conclusion. Research Foundation for Mental Hygiene Inc Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Nixon Ju-Hyun Lee Devin Wolfe Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Active, expires Application number US13/307,485 Other versions US20120136064A1

#Claudia mori alzheimer pdf#

Google Patents Methods for screening to identify therapeutic agents for Alzheimer's disease and use thereofĭownload PDF Info Publication number US9265735B2 US9265735B2 US13/307,485 US201113307485A US9265735B2 US 9265735 B2 US9265735 B2 US 9265735B2 US 201113307485 A US201113307485 A US 201113307485A US 9265735 B2 US9265735 B2 US 9265735B2 Authority US United States Prior art keywords cells lysosomal activity subject atpase Prior art date Legal status (The legal status is an assumption and is not a legal conclusion. Google Patents US9265735B2 - Methods for screening to identify therapeutic agents for Alzheimer's disease and use thereof US9265735B2 - Methods for screening to identify therapeutic agents for Alzheimer's disease and use thereof













Claudia mori alzheimer